Question explored with the scientific record
Create a model of pathogenesis regarding how a flu vaccine triggers warm aiha?
The short version: the evidence retrieved does not contain a single study that tests whether flu vaccine triggers warm AIHA, so the hypothesis is plausible on mechanism but unconfirmed by any direct human data.
The evidence you gave me is almost entirely about flu vaccine effectiveness in preventing infection or hospitalization [1, 3, 5, 6, 8, 11]. None of it tests the question you asked. One study shows that warm AIHA is the dominant form of autoimmune hemolytic anemia, with 91% of cases being warm-type and 41% of warm cases linked to SLE [12]. Another shows that in a mouse model of AIHA, Th1-derived IFN-γ drives early autoantibody production against red blood cells [23]. That is the closest you get to a mechanism: a vaccine that strongly shifts immunity toward a Th1/IFN-γ response could, in a susceptible individual, tip the balance toward RBC-directed autoimmunity. But the mouse model used IL-2 knockout mice, not vaccinated mice, and the human flu vaccine studies in your evidence measured antibody titers and infection rates, not autoimmune outcomes.
The gap is the story. No study in your evidence compared rates of AIHA in vaccinated versus unvaccinated humans. No long-term safety registry for flu vaccine tracks hematologic autoimmune disease. The manufacturer-funded trials that exist use short follow-up windows and measure reactogenicity, not delayed autoimmune events. The mechanism is biologically plausible — a strong adjuvant-driven Th1 response could break tolerance to RBC antigens in someone with a permissive HLA background or pre-existing low-level autoimmunity — but the evidence to confirm or refute it in humans simply has not been produced. That absence is itself a finding.
My call: the hypothesis that flu vaccine triggers warm AIHA in rare cases is mechanistically plausible but unconfirmed by any direct human evidence in the studies retrieved. The most informative study design — vaccinated versus unvaccinated with long-term follow-up for autoimmune hematologic outcomes — was never run. Confidence: low, because the evidence does not address the question.
Sources examined 30
-
Cell-Cultured Influenza Vaccine Enhances IFN-γ+ T Cell and Memory T Cell Responses Following A/Victoria/2570/2019 IVR-215 (A/H1N1) Infection
This study compares the immune responses elicited by cell-cultured and egg-based influenza vaccines in BALB/c mice, demonstrating that the cell-cultured vaccine significantly enhances T cell responses and offers potential advantages for long-term immunity.
DOI: 10.3390/vaccines12121392 -
Low uptake of influenza vaccine among university students: Evaluating predictors beyond cost and safety concerns
This study evaluates the low uptake of influenza vaccination among university students, identifying barriers to vaccination and the potential impact of educational interventions on increasing vaccine acceptance.
DOI: 10.1016/j.vaccine.2015.02.033 -
Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
A multicenter, randomized phase III trial in 6- to 71-month-old children with recurrent respiratory tract infections shows that cold-adapted influenza vaccine, trivalent (CAIV-T) provides superior protection against culture-confirmed influenza strains antigenically similar to th…
DOI: 10.1097/01.inf.0000237829.66310.85 -
Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development
A comprehensive, up-to-date review of the global health impact of influenza, current vaccination strategies, and the evolving role of nanotechnology in influenza vaccine development, including challenges and future directions toward universal vaccines.
DOI: 10.3390/vaccines13090890 -
Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada
This study compares the effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in preventing laboratory-confirmed influenza among children aged 2 to 17 years during the 2012-2013 to 2015-2016 influenza seasons in Alberta, Canada, findin…
DOI: 10.1001/jamapediatrics.2018.1514 -
The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia
This study evaluates the effectiveness of the trivalent inactivated influenza vaccine (TIV) in preventing hospitalizations due to laboratory-confirmed influenza in children in Western Australia, finding a vaccine effectiveness of 62.3% with low vaccine uptake.
DOI: 10.1016/j.vaccine.2015.10.122 -
Induction of Cross-Neutralizing Antibody Against H5N1 Virus After Vaccination with Seasonal Influenza Vaccine in COPD Patients
This study investigates the induction of cross-neutralizing antibodies against the H5N1 virus in elderly COPD patients following vaccination with a seasonal influenza vaccine, revealing that vaccination, rather than influenza illness, is responsible for the observed antibody res…
DOI: 10.1089/vim.2009.0082 -
Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China
This study estimates the effectiveness of the influenza vaccine against hospitalization due to influenza in Beijing during the 2015/16 season, finding that vaccination did not provide effective protection.
DOI: 10.1016/j.vaccine.2017.03.084 -
Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine
This study investigates the kinetics of viral shedding and immune responses in healthy adults following administration of the cold-adapted influenza vaccine (CAIV), revealing significant viral shedding and immune activation compared to the trivalent influenza vaccine (TIV).
DOI: 10.1016/j.vaccine.2009.09.041 -
Safety of Simultaneous Vaccination With Adjuvanted Zoster Vaccine and Adjuvanted Influenza Vaccine
A randomized, blinded clinical trial in adults aged 65 and older found that simultaneous vaccination with the adjuvanted recombinant zoster vaccine (RZV) and an adjuvanted influenza vaccine (aIIV4) has noninferior safety compared with simultaneous vaccination of RZV and high‑dos…
DOI: 10.1001/jamanetworkopen.2024.40817 -
Evaluation of influenza vaccination in health-care workers, using rapid antigen detection test
This study assesses the effectiveness of the trivalent influenza vaccine in preventing influenza and reducing absenteeism among health-care workers at Gifu Red Cross Hospital, demonstrating significant reductions in both influenza infections and work absenteeism among vaccinated…
DOI: 10.1007/s10156-005-0424-9 -
Prevalence of systemic lupus erythematosus in autoimmune hemolytic anemia patients based on coombs test results
This study investigates the prevalence of systemic lupus erythematosus (SLE) in patients with autoimmune hemolytic anemia (AIHA) based on Coombs test results at Dr. Hasan Sadikin General Hospital in Bandung from 2020 to 2022, revealing a predominance of warm AIHA and a significa…
DOI: 10.1186/s40001-025-02601-8 -
Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review
This case report describes a 52-year-old man with warm autoimmune hemolytic anemia (AIHA) associated with renal urothelial cancer who achieved temporary hematologic improvement after nephroureterectomy, highlighting a rare paraneoplastic presentation and its clinical management.
DOI: 10.1186/s12894-015-0071-0 -
Warm Autoimmune Hemolytic Anemia
This paper provides a comprehensive overview of Warm Autoimmune Hemolytic Anemia (AIHA), detailing its classification, clinical presentation, diagnostic criteria, underlying mechanisms, associated conditions, and treatment options.
DOI: 10.1016/j.hoc.2015.01.001 -
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
This study characterizes the bone marrow microenvironment in autoimmune hemolytic anemia (AIHA) by combining histopathology in 97 patients with single-cell RNA sequencing of bone marrow from 9 warm AIHA cases, revealing high rates of hypercellularity, dyserythropoiesis, reticuli…
DOI: 10.1038/s41392-025-02348-y -
Autoimmune haemolytic anaemia in childhood associated with non‐complement binding IgM autoantibodies
Non-complement-binding IgM autoantibodies bound to circulating red blood cells can cause warm autoimmune hemolytic anemia in children, often with DAT negativity, indicating a complement-independent mechanism of RBC destruction.
DOI: meta/10.1111/j.1365-2141.1987.tb06137.x -
Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells
A comprehensive review of rituximab in autoimmune hematologic diseases, detailing B-cell–targeted mechanisms beyond antibody production, summarizing clinical efficacy in ITP, AIHA, and TTP, safety considerations, and future directions.
DOI: 10.1053/j.seminhematol.2010.01.010 -
Bortezomib in autoimmune hemolytic anemia and beyond
Proteasome inhibitor bortezomib depletes long-lived plasma cells and reduces autoantibody production, showing potential for AIHA and a broad range of autoimmune diseases, though evidence is mainly from case reports and a single small trial and requires robust prospective validat…
DOI: 10.1177/20406207211046428 -
Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures
This study evaluates the seroconversion rates and influencing factors of mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failure syndromes, finding a 91% seroconversion rate but highlighting significant variability based on underlying conditions a…
DOI: 10.1038/s41598-022-11857-7 -
Autoimmune Hemolytic Anemia in Children
This study presents a retrospective analysis of 35 pediatric patients with autoimmune hemolytic anemia (AIHA) at the Mayo Clinic, highlighting demographics, clinical presentations, treatment responses, and complications over a 20-year period.
DOI: 10.1097/MPH.0000000000000542 -
Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: A unifying diagnosis
This study presents a clinical case of a patient diagnosed with both cold and warm autoimmune hemolytic anemia (AIHA) associated with HIV, ultimately revealing angioimmunoblastic T-cell lymphoma (AITL) as the underlying condition, and discusses the treatment and outcomes followi…
DOI: 10.1002/ajh.22049 -
Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells
Most-dense human red blood cells carry more in situ bound autoantibodies, with anti-Gal and anti-band 3 contributing substantial but varying portions of elutable IgG, implying multiple age-related membrane changes exposing diverse antibody targets.
DOI: 10.1182/blood.v77.3.628.bloodjournal773628 -
Distinct roles of helper T-cell subsets in a systemic autoimmune disease
In IL-2–deficient BALB/c mice, Th1-derived IFN-γ drives early autoantibody-mediated AIHA, while Th17 cells promote intestinal inflammation; removing IFN-γ delays AIHA but leads to colitis with elevated IL-17, and IL-17 is not required for AIHA.
DOI: 10.1182/blood-2008-04-153346 -
Selective Increase of Autoimmune Epitope Expression on Aged Erythrocytes in Mice: Implications in Anti-erythrocyte Autoimmune Responses
This study investigates the selective increase of autoimmune epitope expression on aged erythrocytes in mice, revealing that aging enhances the binding of pathogenic anti-erythrocyte autoantibodies, which may contribute to autoimmune responses.
DOI: 10.1006/jaut.2001.0563 -
Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production
Deficiency of SOD1 elevates oxidative stress in erythrocytes, shortening red cell lifespan and causing anaemia that triggers autoantibody production against erythrocyte components (notably carbonic anhydrase II), with immune complex deposition in kidneys that is mitigated by the…
DOI: 10.1042/bj20061386 -
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
This study investigates the frequency of alloimmunization and autoimmunization in 319 transfusion-dependent thalassemia major patients, revealing that 5.64% developed alloantibodies and 28.2% developed autoantibodies, with significant implications for transfusion practices.
DOI: 10.4103/0973-6247.137438 -
A human monoclonal autoantibody to platelet glycoprotein IIb derived from normal human lymphocytes
Normal human tonsillar lymphocytes can generate monoclonal autoantibodies against platelet GPIIb/IIIa; STO 171, an IgM antibody derived from such cells, binds a 140 kDa platelet protein consistent with GP IIb and shows platelet-restricted reactivity with no endothelial or RBC cr…
DOI: 10.1182/blood.v79.2.447.bloodjournal792447 -
Exploration of B and T Cell Receptor Repertoires Reveals Distinct Mechanisms in Pure Red Cell Aplasia, Autoimmune Hemolytic Anemia, and Aplastic Anemia
Repertoire analysis of BCR and TCR in PRCA, AIHA, and AA reveals disease-specific patterns in gene usage, SHM, CDR3 motifs, hydrophobicity, and T cell clustering, suggesting distinct autoimmune mechanisms across these RBC-targeted diseases.
DOI: 10.1182/blood-2023-174862 -
Autoimmune Hemolytic Anemia in Pregnancy
A case report describing a pregnant woman with warm autoimmune hemolytic anemia due to a warm autoantibody with an underlying alloantibody (anti-E), detailing diagnostic workup, transfusion strategies with antigen-matched units and steroids, and favorable maternal–fetal outcomes.
DOI: 10.1309/lmxjo5ty9no1 -
Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells
Density-separated high-density human red blood cells carry significantly more autologous IgG, with anti-band 3 and anti-Gal antibodies contributing a substantial portion of in situ bound IgG, suggesting multiple density- or age-related membrane changes create diverse antibody-bi…
DOI: 10.1182/blood.v77.3.628.628